ARCHIVES

Trials Approved In October

This article is from The Cancer Letter archive.

Vol. 24 No. 12 | December 28, 2001

Download PDF Visit The Full Archive

Related Articles

Kyprolis Demonstrates Overall Response Following FDA Accelerated Approval

August 31, 2012

In Brief: HSAs Would Delay NCI Awards By Nine Months; Mary Lasker Names to Carter Health Group

September 17, 1976

Preventive Oncology Announcement Withdrawn For Modification

April 3, 1981

Clinical Oncology Grant Funding: The History Of a Controversy

July 23, 1993

ORI Whistle-Blower Proposal Too Rigid, Biologists Say.

February 2, 2001

Doubling Budget For NSF High Priority For FASEB.

April 20, 2001